Modern strategies for using interleukin 2 in the treatment of cancer: a review and meta-analysis
Interleukin-2 (IL-2) is one of the key cytokines with pleiotropic effects on the immune system. IL-2 has been approved for the treatment of metastatic renal cell carcinoma and metastatic melanoma. Recent advances in understanding the role of IL-2 in the regulation of antitumor immunity have opened new promising avenues...